Intermediate-Term Prognostic Value of Homocysteine in Acute Coronary Syndrome Complicated with or without Hypertension: A Multicenter Observational Cohort Study
Background: As a classical biomarker associated with hypertension, the prognostic value of homocysteine (Hcy) in the intermediate-term outcome of acute coronary syndrome (ACS) remains controversial. This study aimed to investigate the role of homocysteine in ACS patients with different blood pressur...
Main Authors: | Qiang Chen, Shiqiang Xiong, Xunshi Ding, Xiuqiong Yu, Caiyan Cui, Hong Su, Yu Long, Yan Luo, Zhen Zhang, Hanxiong Liu, Tao Xiang, Lin Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2023-07-01
|
Series: | Reviews in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/RCM/24/7/10.31083/j.rcm2407210 |
Similar Items
-
Homocysteine, Β Vitamins and Immune Activation in Coronary Heart Disease
by: Frick Barbara, et al.
Published: (2003-08-01) -
Homocysteine and Risk of Premature Coronary Heart Disease
by: Lutfi Zylbeari, et al.
Published: (2020-07-01) -
Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01) -
Effect of Homocysteine on the Cardiac Function and Coronary Flow in the Isolated Heart of Rat
by: Daryoosh Shackebaei, et al.
Published: (2007-09-01) -
Clinical value and expression of Homer 1, homocysteine, S-adenosyl-l-homocysteine, fibroblast growth factors 23 in coronary heart disease
by: Zhixin Zhang, et al.
Published: (2022-05-01)